Lab values

Platelets lab values

The platelet count tells how many platelets circulate in the blood. Platelets are small cell fragments made in the bone marrow that plug a damaged vessel and start a clot. The count is part of the complete blood count. It is ordered to look for the cause of bruising or bleeding, to screen before surgery and procedures, and to follow clients on chemotherapy, heparin or other drugs that lower the count.

Checked against the sources below November 2026

Normal range

TestUS unitsSI unitsNotes
Platelets150,000–400,000/mm³150–400 × 10⁹/L

Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All hematology values

Platelets in the ICU

Thrombocytosis

A high count is often reactive, from infection, inflammation, iron deficiency or cancer. Essential thrombocythemia is considered above 450,000/mm³, and near 1,000,000/mm³ it can paradoxically raise bleeding risk.

Causes

Signs and symptoms

Nursing actions

  1. Look for the cause, such as signs of infection or low iron studies
  2. Assess for signs of a clot: unilateral leg swelling, chest pain, dyspnea, new neuro deficits
  3. Assess for bruising and bleeding when the count is near or above 1,000,000/mm³
  4. Teach the client with essential thrombocythemia to report headache, burning hands or feet, or signs of a clot
  5. Give antiplatelet or cytoreductive drugs as ordered and watch for bleeding

Thrombocytopenia

Minor bleeding after injury can occur from 20,000 to 50,000/mm³. Spontaneous bleeding can occur at or below 20,000/mm³, and at or below 5,000/mm³ it may be severe or life threatening.

Causes

Signs and symptoms

Nursing actions

  1. Assess skin, gums, urine, stool and emesis for bleeding, and check neuro status for signs of brain bleeding
  2. Start bleeding precautions: soft toothbrush, electric razor only, no enemas or rectal suppositories, no hard nose blowing
  3. Apply pressure to puncture sites and cuts until bleeding stops, and report bleeding that lasts more than 10 minutes
  4. Hold aspirin and NSAIDs and ask the prescriber before giving them
  5. Report a platelet fall of more than 50% in a client on heparin, and anticipate an order to stop all heparin
  6. Give platelets as ordered and monitor for transfusion reactions
  7. Teach the client to prevent constipation, avoid contact sports and alcohol, and report black stools or blood in urine

Drawing and reading the sample

On the exam

Check yourself: 4 questions

Question 1 · Blood Product Transfusions

Which patient has the STRONGEST indication for platelet transfusion?

  1. Subdural hematoma for craniotomy; platelets 78,000
  2. Sepsis, not bleeding, no procedures; platelets 40,000
  3. Leukemia, stable, not bleeding; platelets 18,000
  4. Suspected HIT, not bleeding; platelets 35,000
Show the answer and rationale

Answer: A

  • A. Correct. For intracranial bleeding and neurosurgery, a threshold of about 100,000 is commonly used.
  • B. Prophylactic transfusion is not indicated at this count without bleeding or a planned procedure.
  • C. The prophylactic threshold in stable, non-bleeding patients is usually 10,000.
  • D. Platelets are generally avoided in HIT without major bleeding because they may fuel thrombosis.

Platelet thresholds depend on the clinical context. Common thresholds are below about 10,000 for stable, non-bleeding patients (including consumptive thrombocytopenia such as sepsis) and for central line placement at a compressible site, below about 20,000 for lumbar puncture or low-risk interventional radiology procedures, below about 50,000 for active bleeding, major surgery, or high-risk procedures, and below about 100,000 for CNS bleeding, neurosurgery, or eye surgery. Platelets are relatively contraindicated in HIT and TTP unless there is life-threatening bleeding. One adult dose (apheresis or pooled) raises the count by about 30,000–50,000.

Sources: AACN Core Curriculum, 8th ed.; AABB/ICTMG Platelet Transfusion (2025)

Question 2 · Blood Product Transfusions

A multiparous woman develops a platelet count of 4,000/µL with wet purpura 8 days after an RBC transfusion. She has had no heparin exposure. Testing shows an anti-HPA-1a antibody. Which treatment is MOST appropriate?

  1. Fresh frozen plasma infusion
  2. Random-donor platelet transfusion
  3. IV immune globulin (IVIG)
  4. Argatroban anticoagulation
Show the answer and rationale

Answer: C

  • A. FFP does not treat antibody-mediated platelet destruction.
  • B. Transfused platelets are rapidly destroyed in PTP and may worsen the reaction.
  • C. Correct. IVIG is first-line for post-transfusion purpura and typically raises platelet counts within days.
  • D. Argatroban is for HIT, which is excluded here by the lack of heparin exposure.

Post-transfusion purpura is a rare, severe thrombocytopenia that occurs 5–12 days after transfusion, typically in women sensitized by pregnancy to a platelet antigen (most often HPA-1a). The recall antibody destroys both transfused and the patient’s own antigen-negative platelets, through mechanisms that are still unclear. Treatment is high-dose IVIG, with plasma exchange for refractory cases, and future transfusions should use antigen-negative products.

Sources: Goldman-Cecil Medicine, 27th ed.

Question 3 · Sepsis & Surviving Sepsis Campaign

A patient with septic shock and a platelet count of 92,000, with no active bleeding, needs VTE prophylaxis. Which approach is MOST appropriate?

  1. Pharmacologic prophylaxis with LMWH
  2. Mechanical SCDs only, avoiding heparin
  3. No prophylaxis, since sepsis causes bleeding
  4. Low-dose aspirin as the sole prophylaxis
Show the answer and rationale

Answer: A

  • A. Correct. The SSC recommends pharmacologic prophylaxis unless contraindicated and recommends LMWH over unfractionated heparin.
  • B. Mechanical prophylaxis is used when pharmacologic prophylaxis is contraindicated, which is not the case here.
  • C. Sepsis is prothrombotic, and critically ill septic patients are at high VTE risk.
  • D. Aspirin is not recommended for VTE prophylaxis in sepsis.

Sepsis increases VTE risk through inflammation, immobility, central lines, and vasopressors. The SSC recommends pharmacologic prophylaxis with LMWH over UFH (dose-adjusted for renal function) unless there is active bleeding, severe thrombocytopenia (commonly below about 30,000–50,000), or other contraindications. Moderate thrombocytopenia without bleeding does not automatically preclude prophylaxis.

Sources: Surviving Sepsis Campaign 2026; ASH VTE Prophylaxis, Medical Patients (2018)

Question 4 · Blood Product Transfusions

On day 3 of septic shock with multiple organ dysfunction, a patient has a platelet count of 14,000/mm³ (210,000 on admission) with no bleeding and an INR of 1.4. A new ultrasound-guided right internal jugular central venous catheter is needed for vasopressors. Which plan is MOST consistent with the 2025 AABB/ICTMG platelet guideline?

  1. Transfuse to a count of 50,000 before insertion
  2. Transfuse 1 unit of platelets right before insertion
  3. Transfuse platelets daily to keep the count above 20,000
  4. Place the catheter without a platelet transfusion
Show the answer and rationale

Answer: D

  • A. 50,000 is the threshold for major nonneuraxial surgery and high-risk interventional procedures, not for an ultrasound-guided jugular line.
  • B. Tempting as a cautious middle course, but at 14,000 the count is above the 10,000 threshold for a compressible-site line, so transfusion adds risk without benefit.
  • C. 20,000 is the threshold for lumbar puncture; nonbleeding adults with consumptive thrombocytopenia are transfused only below 10,000.
  • D. Correct. For central line placement at a compressible site, the guideline suggests platelet transfusion only when the count is below 10,000.

Sepsis consumes platelets, and transfused platelets survive poorly in a consumptive process, so the 2025 AABB/ICTMG guideline sets low thresholds. For nonbleeding adults with consumptive thrombocytopenia it suggests transfusion below 10,000/mm³, and for central venous catheter placement at a compressible site such as the internal jugular vein the threshold is also 10,000. Ultrasound guidance and a compressible site lower bleeding risk further. Higher thresholds apply to lumbar puncture (20,000), major nonneuraxial surgery (50,000) and active major bleeding. The nurse still watches the site and holds pressure after insertion.

Sources: AABB/ICTMG Platelet Transfusion (2025)

Practice this in the app

ICU Basics has 85 questions on electrolyte imbalances, each with a rationale for every choice. No ads. Pro is coming in January 2027.

Practice in your browser

Download on theApp StoreGet it onGoogle Play

Study the topic

Electrolyte Imbalance practice questions

Other lab values

Sources

  1. Merck Manual Professional Edition. Overview of Platelet Disorders. 2025.
  2. Merck Manual Professional Edition. Thrombocytopenia: Other Causes (heparin-induced thrombocytopenia, sepsis). 2025.
  3. Merck Manual Professional Edition. Essential Thrombocythemia. 2025.
  4. MedlinePlus. Bleeding during cancer treatment. National Library of Medicine.
  5. Ng JY, D'Souza M, Hutani F, Choi P. Management of Heparin-Induced Thrombocytopenia: A Contemporary Review. J Clin Med. 2024;13(16):4686.
  6. AABB. AABB Develops New Platelet Transfusion Guidelines (summary of Metcalf RA et al. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA. 2025;334:606-617). 2025.
  7. Shah A, Dohner J, Cheng K, Garcia M, Kost GJ. Visualization of Critical Limits and Critical Values Facilitates Interpretation. Diagnostics (Basel). 2025;15(5):604.
  8. Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline

For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.